Everdime Technologies, Inc.
RGST · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -66.9% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 26.9% | 68.6% | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -52.2% | -21.4% | – | – |
| Other Income/Exp. Net | -$1 | -$0 | -$2 | -$0 |
| Pre-Tax Income | -$1 | -$0 | -$2 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$0 | -$2 | -$0 |
| % Margin | -1,091.3% | -21.9% | – | – |
| EPS | -0.006 | -0 | -0.015 | -0 |
| % Growth | -1,500% | 97.4% | -7,450% | – |
| EPS Diluted | -0.006 | -0 | -0.015 | -0 |
| Weighted Avg Shares Out | 155 | 149 | 142 | 34 |
| Weighted Avg Shares Out Dil | 155 | 149 | 142 | 34 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -74.5% | -21.4% | – | – |